The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma
Open accessAbstract
An understanding of the process by which tumor cells destroy the basement membrane of the surface epithelium, invade, and metastasize is essential to the development of novel treatment of head and neck squamous cell carcinoma (HNSCC). In recent years, there has been increased interest in the role of epithelial-mesenchymal transition (EMT) in invasion. EMT is a process that describes the development of motile, mesenchymal-like cells from non-motile parent epithelial cells. There are 3 known types of EMT that mediate development, wound healing, and carcinogenesis. This review summarizes studies of known EMT biomarkers in the context of HNSCC progression. The biomarkers discussed come from a wide range of proteins, including cell-surface proteins (E-cadherin, N-cadherin, and Integrins), cytoskeletal proteins (α-Smooth Muscle Actin, Vimentin, and β-catenin), extracellular matrix proteins (Collagens, Fibronectin, and Laminin), and transcription factors (SNAIL1, SNAIL2, TWIST, and LEF-1). Overall, the findings of these studies suggest that EMT mediates HNSCC progression. The mechanistic role of the EMT markers that have been associated with HNSCC should be more clearly defined if new anti-HNSCC therapies to block EMT progression are to be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 20×
“Expression of zona-occludens 1 (ZO-1) occurs in all 3 types of EMT (Zeisberg and Neilson, 2009).”
BackgroundInfluentialDynamic interplay between the collagen scaffold and tumor evolution
Egeblad, M., Rasch, M. G., & Weaver, V. M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.015 · Cited by 896
Cadherins as Modulators of Cellular Phenotype
Wheelock, M. J., & Johnson, K. R. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.011102.111135 · Cited by 672
Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
Yang, M.-H., Hsu, D. S.-S., Wang, H.-W., Wang, H.-J., Lan, H.-Y., Yang, W.-H., Huang, C.-H., Kao, S.-Y., Tzeng, C.-H., Tai, S.-K., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2099 · Cited by 631
Breaching the basement membrane: who, when and how?
Rowe, R. G., & Weiss, S. J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.007 · Cited by 443
Biddle, A., Liang, X., Gammon, L., Fazil, B., Harper, L. J., Emich, H., Costea, D. E., & Mackenzie, I. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1059 · Cited by 356
Laminin 332 in squamous-cell carcinoma
Marinkovich, M. P. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2089 · Cited by 299
Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Foroni, C., Broggini, M., Generali, D., & Damia, G. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.001 · Cited by 282
Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma
Chen, C., Méndez, E., Houck, J., Fan, W., Lohavanichbutr, P., Doody, D., Yueh, B., Futran, N. D., Upton, M., Farwell, D. G., et al. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2893 · Cited by 270
Chen, C., Wei, Y., Hummel, M., Hoffmann, T. K., Gross, M., Kaufmann, A. M., & Albers, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016466 · Cited by 235
β-Catenin and Tcfs in Mammary Development and Cancer
Hatsell, S., Rowlands, T., Hiremath, M., & Cowin, P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025944723047 · Cited by 209
Lysyl Oxidase–Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
Peinado, H., Moreno-Bueno, G., Hardisson, D., Pérez-Gómez, E., Santos, V., Mendiola, M., de Diego, J. I., Nistal, M., Quintanilla, M., Portillo, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6345 · Cited by 205
ZEB1-responsive genes in non-small cell lung cancer
Gemmill, R. M., Roche, J., Potiron, V. A., Nasarre, P., Mitas, M., Coldren, C. D., Helfrich, B. A., Garrett-Mayer, E., Bunn, P. A., & Drabkin, H. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.09.007 · Cited by 179
Mh, Y., Chang, S.-Y., Chiou, S.-H., Liu, C.-J., Cw, C., Pm, C., Teng, S.-C., & Kj, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209929 · Cited by 167
Hsu, D. S., Lan, H., Huang, C.-H., Tai, S., Chang, S., Tsai, T.-L., Chang, C., Tzeng, C., Wu, K.-J., Kao, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0593 · Cited by 157
Polette, M., Mestdagt, M., Bindels, S., Nawrocki‐Raby, B., Hunziker, W., Foidart, J., Birembaut, P. L., & Gilles, C. (2007) · Cells Tissues Organs · doi:10.1159/000101304 · Cited by 155
Yang, Z., Zhang, X., Gang, H., Li, X., Li, Z., Wang, T., Han, J., Luo, T. L., Wen, F., & Wu, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.023 · Cited by 151
Cancer Stem Cells and Novel Targets for Antitumor Strategies
Prud’homme, G. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626120 · Cited by 150
Changes in gene expression during progression of ovarian carcinoma
Tapper, J., Kettunen, E., El-Rifai, W. M., Seppälä, M. T., Andersson, L. C., & Knuutila, S. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00386-7 · Cited by 141
Yoon, Y., Liang, Z., Zhang, X., Choe, M., Zhu, A., Cho, H. T., Shin, D. M., Goodman, M. M., Chen, Z., & Shim, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2263 · Cited by 134
Interaction between HSP60 and β-catenin promotes metastasis
Tsai, Y., Yang, M., Huang, C.-H., Chang, S., Chen, P., Liu, C., Teng, S., & Wu, K.-J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp087 · Cited by 125
Huang, C.-H., Yang, W., Chang, S., Tai, S., Tzeng, C., Kao, J., Wu, K.-J., & Yang, M. (2009) · Neoplasia · doi:10.1593/neo.91326 · Cited by 123
Molecular determinants of Akt-induced keratinocyte transformation
Segrelles, C., Moral, M., Lara, M. F., Ruiz, S., Santos, M., Leis, H., García‐Escudero, R., Martínez‐Cruz, A. B., Martínez‐Palacio, J., Hernández, P., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209155 · Cited by 109
Snail Up-regulates Proinflammatory Mediators and Inhibits Differentiation in Oral Keratinocytes
Lyons, J. G., Patel, V., Roue, N. C., Fok, S., Soon, L., Halliday, G. M., & Gutkind, J. S. (2008) · Cancer Research · doi:10.1158/1078-0432.ccr-07-6735 · Cited by 107
Tijink, B. M., Neri, D., Leemans, C. R., Budde, M., Dinkelborg, L. M., van Walsum, M., Zardi, L., & van Dongen, G. A. M. S. (2006) · PubMed · Cited by 104
Lim, K. P., Cirillo, N., Hassona, Y. M., Wei, W., Thurlow, J. K., Cheong, S. C., Pitiyage, G. N., Parkinson, E. K., & Prime, S. S. (2010) · The Journal of Pathology · doi:10.1002/path.2841 · Cited by 95
Paccione, R. J., Miyazaki, H., Patel, V., Waseem, A., Gutkind, J. S., Zehner, Z. E., & Yeudall, W. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0450 · Cited by 95
Interaction between integrin α5 and fibronectin is required for metastasis of B16F10 melanoma cells
Feng, Q., Zhang, Z.-C., Wu, X., Li, Y., & Xu, Q. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.039 · Cited by 94
Montserrat, N., Gallardo, A., Escuín, D., Catasús, L., Prat, J., Gutiérrez-Aviñó, F. J., Peiró, G., Barnadas, A., & Lerma, E. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.05.019 · Cited by 93
Drake, J. M., Barnes, J. M., Madsen, J. M., Domann, F. E., Stipp, C. S., & Henry, M. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136044 · Cited by 84
Mitra, R. S., Goto, M., Lee, J. J., Maldonado, D., Taylor, J. M. G., Pan, Q., Carey, T. E., Bradford, C. R., Prince, M. E., Cordell, K. G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2755 · Cited by 73
Self-citationDooley, T. P., Reddy, S. P., Wilborn, T. W., & Davis, R. L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01099-4 · Cited by 73
Tubergen, E. V., Broek, R. V., Lee, J. J., Wolf, G. T., Carey, T. E., Bradford, C. R., Prince, M. E., Kirkwood, K. L., & D’Silva, N. J. (2011) · Cancer · doi:10.1002/cncr.25859 · Cited by 69
Self-citationChang, H. W., Roh, J., Jeong, E., Lee, S., Kim, S., Choi, S., Park, S., & Kim, S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.23069 · Cited by 67
Goto, M., Mitra, R. S., Liu, M., Lee, J. J., Henson, B. S., Carey, T. E., Bradford, C. R., Prince, M. E., Wang, C.-Y., Fearon, E. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1122 · Cited by 67
Self-citationMéndez, E., Houck, J. R., Doody, D. R., Fan, W., Lohavanichbutr, P., Rue, T. C., Yueh, B., Futran, N. D., Upton, M. P., Farwell, D. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1816 · Cited by 64
Zhao, Z., Ge, J., Sun, Y., Tian, L., Lu, J., Liu, M., & Zhao, Y. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.02.024 · Cited by 60
Jouppila‐Mättö, A., Närkiö‐Mäkelä, M., Soini, Y., Pukkila, M. J., Sironen, R. K., Tuhkanen, H. E., Mannermaa, A., & Kosma, V. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-350 · Cited by 55
Economic burden of head and neck cancer
(2004) · doi:10.1007/s10198-003-0204-3 · Cited by 50
Nakahara, S., Miyoshi, E., Noda, K., Ihara, S., Gu, J., Honke, K., Inohara, H., Kubo, T., & Taniguchi, N. (2003) · PubMed · Cited by 49
Localization of cortactin is associated with colorectal cancer development
Hirakawa (2009) · International Journal of Oncology · doi:10.3892/ijo_00000444 · Cited by 45
Zonula Occludens-1, Occludin, and E-cadherin Protein Expression in Biliary Tract Cancers
Németh, Z., Szász, A. M., Somorácz, Á., Tátrai, P., Németh, J., Győrffy, H., Szíjártó, A., Kupcsulik, P., Kiss, A., & Schaff, Z. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9150-4 · Cited by 44
The economics of squamous cell carcinoma of the head and neck
Menzin, J., Lines, L. M., & Manning, L. N. (2007) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328017f669 · Cited by 42
Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma
Mendelsohn, A. H., Lai, C. K., Shintaku, I. P., Fishbein, M. C., Brugman, K., Elashoff, D. A., Abemayor, E., Dubinett, S. M., & John, M. A. S. (2011) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2010.11.018 · Cited by 37
Farina, A., Bong, Y., Feltes, C. M., & Byers, S. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004797 · Cited by 35
Warawdekar, U. M., Zingde, S. M., Iyer, K. S. N., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.023 · Cited by 33
Huang, D., Su, L., Peng, X.-H., Zhang, H., Khuri, F. R., Shin, D. M., & Chen, Z. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/22/225102 · Cited by 33
Aberrant type I and type III collagen gene expression in human breast cancerin vivo
Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., & Risteli, L. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(1998110)186:3
Cited by
Endothelial-to-mesenchymal transition drives atherosclerosis progression
Chen, P.-Y., Qin, L., Baeyens, N., Li, G., Afolabi, T., Budatha, M., Tellides, G., Schwartz, M. A., & Simons, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82719 · Cited by 588
Biomaterials for Integration with 3-D Bioprinting
Skardal, A., & Atala, A. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1207-1 · Cited by 474
Inflammatory Response Mechanisms of the Dentine–Pulp Complex and the Periapical Tissues
Galler, K. M., Weber, M., Korkmaz, Y., Widbiller, M., & Feuerer, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031480 · Cited by 455
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer
Tania, M., Khan, M. A., & Fu, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2163-y · Cited by 257
Metadata
- Authors
- Scanlon, C. S., Van Tubergen, E. A., Inglehart, R. C., & D’Silva, N. J.
- Venue
- Journal of Dental Research
- Publisher
- SAGE Publications
- Published
- 2012-11-05
- Volume
- 92
- Issue
- 2
- Pages
- 114-121
- ISSN
- 0022-0345 (ISSN-L)
- 1544-0591
- OpenAlex
- W2080261745
- Cited by
- 331
- References
- 50
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.